We leverage our deep clinical and commercial expertise, supported by an intensive, field-oriented research approach, to address the most complex business challenges. Explore our unique perspectives, innovative methodologies, and the critical insights we provide to help our clients navigate their most pressing issues. Explore our collection of Insights and Resources below to learn more about our unique approach at SAI Med Partners.
Filter By
All Resources
- White Paper
The annual ranking of the world’s leading pharma companies by their ability to create new ideas and turn them into […]
- News
Eli Lilly First Ever Company to Top Both Rankings in the 2026 Pharmaceutical Innovation and Invention Index See the full results at https://www.ideapharma.com/pii/report/global/ LONDON, UK — May 19th 2026 — The 2026 Global Pharmaceutical Innovation […]
- Blog
The Freshness Index shows the percentage of company sales generated by products launched in the last three and five years. […]
- News
Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards […]
- Blog
Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning Introduction: The Wrong Question Pharmaceutical market research is often […]
- White Paper
In Pharmaceutical Positioning, the challenge is to find the perfect combination of what the medical environment needs (even if your […]
The Rare Disease Journey Is More Complex Than Ever Rare disease patient journeys have always been difficult to navigate. Today, […]
- White Paper
The pharmaceutical industry increasingly relies on sophisticated market research to understand healthcare professionals, patients, and stakeholders. However, traditional research methods—while […]
- White Paper
IDEA Pharma work with Biopharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy. The IDEA Pharma […]
- News
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but […]
Let’s Talk Business
Explore our Related Solutions: Delve Deeper
Gain further understanding of our range of related solutions and offerings by exploring each topic individually.